In the attempt to understand in more detail the mechanisms of IFNα in vivo, several studies have recently utilized microarray technologies to detect and analyze an IFNα-specific signature in the peripheral blood cells of IFNα-treated individuals, with particular focus on HCV and melanoma patients [9-15]. This evidence concerns the gene IFNA2 and melanoma.